Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
32 results
D2.332 - Patients With HAE Report Positive Perceptions Following Berotralstat Treatment: Results from a Focus Group
D2.325 - Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study
D2.326 - Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Data Snapshot Results of the CHAPTER-1 Open-Label Extension Study
D2.327 - Outcome of hematopoietic stem cells transplantation for inborn error of immunity in Vietnam
D2.328 - Comparison of the frequency of viral infections in immunocompromised patients receiving immunoglobulin by different routes
D2.329 - Impact of Berotralstat on Quality of Life among Patients with Hereditary Angioedema: Pooled Analysis of the APeX-2 and APeX-J Trials
D2.330 - Hereditary angioedema prophylaxis therapy: berotralstat and lanadelumab safety profile
D2.331 - Lanadelumab safety and efficacy in patients aged ≥12 with hereditary angioedema (HAE) in China for long-term prophylaxis (LTP): An open-label, multicenter study
D2.334 - Real-World Effectiveness of Lanadelumab in Hereditary Angioedema: A 12-Month Retrospective Study at a Single Center in Colombia
D2.336 - Evolution of Hereditary Angioedema Prophylaxis in Hungary Over Four Decades (1979-2023)
D2.338 - The Effect of Covid-19 Vaccines on Adult Primary Immunodeficiency Patients
D2.339 - Hereditary Angioedema Burden: Impact on Quality of Life, Disease Management, and Sleep Health
D2.340 - A high prevalence of autoimmune diseases and autoantibodies in patients with hereditary angioedema in Sweden
D2.366 - The establishment of a Japanese cypress pollen environmental exposure chamber protocol
D2.367 - Omalizumab Efficacy in Relapse of Nasal Polyposis
D2.368 - Lack of anaerobic gut bacteria in patients with aspirin intolerance and allergy
D2.369 - Impaired Retinoic Acid Metabolism and Eotaxin Overexpression in Eosinophilic Chronic Rhinosinusitis: Insights into Pathophysiology and Therapeutic Potential of CRABP1 Targeting
D2.370 - Trends in Sensitization to Pet Allergens and Correlation between Symptoms and Asthma in Allergic Rhinitis from 2017 to 2023 in China
D2.372 - Evaluating ChatGPT's Performance in Answering Questions About Allergic Rhinitis and Chronic Rhinosinusitis
D2.374 - Smoking increases mortality risk of chronic inflammatory airway diseases: a real-world hospital cohort study
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download